Tatsumori Yoshida

Presidente en C&O Pharmaceutical Technology (Holdings) Ltd. .

Consumer Services

Health Technology

Perfil

Tatsumori Yoshida is currently the Non-Executive Chairman at C&O Pharmaceutical Technology (Holdings) Ltd.
He obtained his undergraduate degree from Osaka Prefecture University in 1995.

Cargos activos de Tatsumori Yoshida

Empresas	Cargo	Inicio
C&O Pharmaceutical Technology (Holdings) Ltd. C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong.	Presidente	16/04/2018

Todos los cargos activos de Tatsumori Yoshida

Formación de Tatsumori Yoshida.

Osaka Prefecture University

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Tatsumori Yoshida.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
C&O Pharmaceutical Technology (Holdings) Ltd. C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong.	Health Technology